Hazard Lisa J, Wang Brian, Skidmore Thomas B, Chern Shyh-Shi, Salter Bill J, Jensen Randy L, Shrieve Dennis C
Department of Radiation Oncology, Huntsman Cancer Hospital, University of Utah School of Medicine, Salt Lake City, UT, USA.
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):562-70. doi: 10.1016/j.ijrobp.2008.04.026. Epub 2008 Jun 17.
To assess the conformity of dynamic conformal arc linear accelerator-based stereotactic radiosurgery and to describe a standardized method of isodose surface (IDS) selection.
In 174 targets, the conformity index (CI) at the prescription IDS used for treatment was calculated as CI = (PIV/PVTV)/(PVTV/TV), where TV is the target volume, PIV (prescription isodose volume) is the total volume encompassed by the prescription IDS, and PVTV is the TV encompassed by the IDS. In addition, a "standardized" prescription IDS (sIDS) was chosen according to the following criteria: 95% of the TV was encompassed by the PIV and 99% of TV was covered by 95% of the prescription dose. The CIs at the sIDS were also calculated.
The median CI at the prescription IDS and sIDS was 1.63 and 1.47, respectively (p < 0.001). In 132 of 174 cases, the volume of normal tissue in the PIV was reduced by the prescription to the sIDS compared with the prescription IDS, in 20 cases it remained unchanged, and in 22 cases it was increased.
The CIs obtained with linear accelerator-based stereotactic radiosurgery are comparable to those previously reported for gamma knife stereotactic radiosurgery. Using a uniform method to select the sIDS, adequate target coverage was usually achievable with prescription to an IDS greater than that chosen by the treating physician (prescription IDS), providing sparing of normal tissue. Thus, the sIDS might aid physicians in identifying a prescription IDS that balances coverage and conformity.
评估基于动态适形弧形直线加速器的立体定向放射外科的适形性,并描述一种选择等剂量面(IDS)的标准化方法。
在174个靶区中,将用于治疗的处方IDS处的适形指数(CI)计算为CI =(PIV/PVTV)/(PVTV/TV),其中TV是靶区体积,PIV(处方等剂量体积)是处方IDS所包含的总体积,PVTV是IDS所包含的TV。此外,根据以下标准选择“标准化”处方IDS(sIDS):95%的TV被PIV所包含,99%的TV被95%的处方剂量覆盖。还计算了sIDS处的CI。
处方IDS和sIDS处的CI中位数分别为1.63和1.47(p < 0.001)。在174例中的132例中,与处方IDS相比,处方到sIDS时PIV中的正常组织体积减少,20例保持不变,22例增加。
基于直线加速器的立体定向放射外科获得的CI与先前报道的伽玛刀立体定向放射外科的CI相当。使用统一方法选择sIDS,通常可以通过处方到比治疗医生选择的IDS(处方IDS)更大的IDS来实现足够的靶区覆盖,从而使正常组织得到保护。因此,sIDS可能有助于医生确定平衡覆盖和适形的处方IDS。